The Canberra Hospital
7
2
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research
Role: collaborator
Fibrinolysis Resistance in Infection and Trauma
Role: collaborator
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates
Role: collaborator
An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer
Role: collaborator
TARGET-Metabolic Effects
Role: collaborator
Intravenous Saline Pre-hydration in Patients Undergoing Outpatient Colonoscopy
Role: lead
Dose Enhancement of Vancomycin IN Everyday Patients
Role: lead
All 7 trials loaded